Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Trial of Hypofractionated Radiotherapy to the Whole Breast or Post-Mastectomy Chest Wall Including Regional Nodal Irradiation

NCT04443413 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04443413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04443413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Trial of Hypofractionated Radiotherapy to the Whole Breast or Post-Mastectomy Chest Wall Including Regional Nodal Irradiation
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 16, 2020
Completion date
November 19, 2029
Enrollment
146 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage i breast cancer ajcc v8, anatomic stage ii breast cancer ajcc v8, anatomic stage iii breast cancer ajcc v8